Respiratorius is a research company. Today, the company is mainly focused on development of new drug candidates for the treatment of chronic obstructive pulmonary disease (COPD), asthma and cancer. Additionally, the company focuses on project development in the area of cardiovascular diseases. The company was formed in 1999 as a spin-off from Lund University. The company is based in Lund.

Quotes for Respiratorius AB

Right Now

+/-
0
%
0,00%
Latest
0.481
High
0.49
Low
0.47
Volume
287 275
Turnover (SEK)
138 208
Market Value (MSEK)
140,6
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Niklas Prager

Board

  • Anna Törner
  • Kristina Drott
  • Peter Buhl

Videos

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 10,34 10,34 2022-03-31
Avanza Pension 7,78 7,78 2022-03-31
Valcuria Holding AB 5,27 5,27 2022-04-01
Ben Hayes 2,34 2,34 2022-03-31
Hans Harvig 1,95 1,95 2022-03-31
Benny Bengtsson 1,30 1,30 2022-03-31
Hartmut Wiese 0,99 0,99 2022-03-31
Christian Müller 0,94 0,94 2022-03-31
Handelsbanken Liv Försäkring AB 0,80 0,80 2022-03-31
Hans Mandahl 0,79 0,79 2022-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream